Micropos Medical develops technologies that enhance the precision in radiotherapy of cancer. The first product, RayPilot® is an electromagnetic positioning system that enables real time information of the target position for a fast and objective set-up and for continuous positioning during the treatment.
The RayPilot system is developed for prostate cancer but has the potential for future use in other tumor areas.
By using RayPilot, our ambition is to reduce side effects, increase patient safety and get higher patient throughput which benefits patients and healthcare providers.
Micropos Medical AB (publ) is a company listed on the Swedish stock list AktieTorget under the stock ticker MPOS.